Announcement: 16th International Conference on “Advances in Technology and Business Potential of New Drug Delivery Systems”
The CRS India Local Chapter announces a call for abstracts for the 16th international conference on “Advances in Technology and Business Potential of New Drug Delivery Systems,” which will take place February 23–24, 2018, in Mumbai, India. The venue is Hotel Lalit, Sahar Airport Road, Andheri (East) Mumbai.
In the quest to deliver therapeutic agents with improved efficacy and minimum side effects, novel drug delivery systems (NDDS) have created a paradigm shift in the pharmaceutical market. The thrust behind development of NDDS has increased owing to its manifold advantages such as safety, high efficacy, improved pharmacokinetics, decreased dosing frequency, minimization of side effects on account of targeting capability to a specific site, patient compliance, and economic advantages. The burgeoning interest in NDDS has increased due to advancement and availability of a variety of technologies to deliver drugs in novel dosage forms. The novel drug delivery systems include various nanocarrier-based drug delivery systems such as liposomes, niosomes, micelles, nanoparticles, and so on and administration technologies resulting in site-specific delivery. These delivery systems make it possible to administer drugs through routes that were not explored earlier, such as microneedles for transdermal drug and vaccine delivery, depot systems for intramuscular administration, aerosolized systems for pulmonary delivery, and so on. It is estimated that NDDS products contribute to 17% of the world’s pharma market, amounting to $104 billion.
In view of this, the 16th symposium of CRS India Local Chapter aims to explore the upcoming developments in the field of NDDS and provide a common platform to industry personnel, academicians, research scientists, and students to stimulate discussions on various aspects of development and management of novel delivery systems including regulatory issues and business aspects. Poster sessions will provide opportunities for researchers to showcase their novelty in various aspects of drug delivery and will serve as an interactive forum between delegates from academia and industry.
Nine invited international speakers have confirmed their participation: Per Falk (Ferring Pharmaceuticals, Switzerland), Henning Falck (Neuhaus Neotec, Germany), Michelle Frisch (Powder Systems Ltd., U.S.A.) , Hamid Ghandehari (University of Utah, U.S.A.), Vinod Labhasetwar (Cleveland Clinic, U.S.A.), Dilwyn Patterson (GEA Process Engineering, United Kingdom), Kannan Rangaramanujan ( John Hopkins School of Medicine, U.S.A.), Sudesh Shetty (KPMG, India), and Matthias Wacker (Goethe University, Germany). International coordinators are Vinod Labhasetwar, Ryan Donnelly (Queen’s University, Belfast, Ireland), and Paul Heng (National University of Singapore).
Students, academicians, and researchers are invited to present their research related to the theme of the seminar at the poster presentation competition. The deadline for abstract submission is December 10, 2017, and the registration deadline is January 31, 2018. For further information, please contact secretary.crsic@gmail.com or president.crsic@gmail.com. Please also visit www.crsic.org.
